Your browser is no longer supported. Please, upgrade your browser.
Settings
VNDA Vanda Pharmaceuticals Inc. daily Stock Chart
VNDA [NASD]
Vanda Pharmaceuticals Inc.
Index- P/E37.59 EPS (ttm)0.47 Insider Own3.40% Shs Outstand55.18M Perf Week-3.83%
Market Cap970.62M Forward P/E20.62 EPS next Y0.85 Insider Trans-5.21% Shs Float51.28M Perf Month-12.18%
Income25.20M PEG- EPS next Q0.07 Inst Own- Short Float7.38% Perf Quarter-28.58%
Sales193.10M P/S5.03 EPS this Y236.60% Inst Trans2.00% Short Ratio3.98 Perf Half Y-10.48%
Book/sh5.25 P/B3.35 EPS next Y224.33% ROA8.00% Target Price35.00 Perf Year3.78%
Cash/sh4.66 P/C3.77 EPS next 5Y- ROE9.80% 52W Range13.88 - 33.44 Perf YTD-32.68%
Dividend- P/FCF32.79 EPS past 5Y21.80% ROI7.80% 52W High-47.40% Beta0.49
Dividend %- Quick Ratio5.60 Sales past 5Y41.60% Gross Margin89.40% 52W Low26.77% ATR0.77
Employees270 Current Ratio5.60 Sales Q/Q19.60% Oper. Margin11.20% RSI (14)28.92 Volatility3.71% 3.51%
OptionableYes Debt/Eq0.00 EPS Q/Q558.50% Profit Margin13.10% Rel Volume0.67 Prev Close18.44
ShortableYes LT Debt/Eq0.00 EarningsFeb 13 AMC Payout0.00% Avg Volume949.51K Price17.59
Recom1.80 SMA20-8.74% SMA50-23.01% SMA200-20.08% Volume639,087 Change-4.61%
Dec-11-18Downgrade Oppenheimer Outperform → Perform
Dec-04-18Upgrade Cantor Fitzgerald Neutral → Overweight
Dec-04-18Reiterated Jefferies Buy $30 → $40
Nov-08-18Resumed Jefferies Buy
Sep-21-18Resumed Oppenheimer Outperform
May-23-18Initiated Citigroup Buy $26
Jan-19-18Initiated Seaport Global Securities Buy $20
Sep-14-17Reiterated Piper Jaffray Overweight $23 → $26
Jun-27-17Resumed Piper Jaffray Overweight $23
May-26-17Initiated H.C. Wainwright Buy $18
Apr-12-17Initiated Oppenheimer Outperform $21
Nov-09-16Initiated Aegis Capital Buy $24
Oct-06-16Resumed Jefferies Buy
Jan-09-15Initiated Canaccord Genuity Buy $22
Mar-10-10Initiated Hapoalim Outperform $23
Feb-17-10Reiterated Jefferies & Co Buy $22 → $20
Dec-09-09Initiated Jefferies & Co Buy $22
Jul-29-08Downgrade JP Morgan Overweight → Neutral
Jul-29-08Downgrade Banc of America Sec Buy → Neutral
Jul-28-08Downgrade Caris & Company Buy → Above Average $22 → $3
Mar-22-19 03:55PM  IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:08PM  CLASS ACTION UPDATE for TYME, GE and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Mar-21-19 07:26PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. VNDA GlobeNewswire
05:35PM  SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
04:00PM  SHAREHOLDER ALERT: AVP VNDA WTW: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
03:00PM  Bronstein, Gewirtz & Grossman, LLC Class Action Reminder Vanda Pharmaceuticals Inc. (VNDA), Stamps.com Inc. (STMP) & Diplomat Pharmacy, Inc. (DPLO) - GlobeNewswire
10:50AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CORT, CAG, VNDA and INGN GlobeNewswire
Mar-20-19 08:47PM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. VNDA GlobeNewswire
03:52PM  CLASS ACTION ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Significant Losses From Investment In Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) To Contact Brower Piven Before The Lead Plaintiff Deadline GlobeNewswire
10:44AM  Bronstein, Gewirtz & Grossman, LLC Class Action Reminder Vanda Pharmaceuticals Inc. (VNDA), Stamps.com Inc. (STMP) & Diplomat Pharmacy, Inc. (DPLO) ACCESSWIRE
09:32AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GSM, MU, VNDA and WTW GlobeNewswire
Mar-19-19 08:33PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. VNDA ACCESSWIRE
05:05PM  CLASS ACTION UPDATE for TYME, VNDA and CNDT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
04:28PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals, Inc. To Contact The Firm GlobeNewswire
12:13PM  SHAREHOLDER ALERT: AVP DPLO VNDA CTL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
11:06AM  April 26th Vanda (VNDA) Deadline: Bernstein Liebhard LLP Reminds Investors of the Important Upcoming Deadline in the Shareholder Class Action Lawsuit Against Vanda Pharmaceuticals Inc. VNDA GlobeNewswire
10:44AM  Class Action Reminder Vanda Pharmaceuticals Inc. (VNDA), Stamps.com Inc. (STMP) & Diplomat Pharmacy, Inc. (DPLO) - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Mar-17-19 10:10AM  CLASS ACTION UPDATE for GSM, WRCDF, CAG and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Mar-15-19 07:27PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc. VNDA GlobeNewswire
Mar-14-19 05:45PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of MAXR, VNDA and CTL ACCESSWIRE
04:40PM  INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
04:00PM  CLASS ACTION UPDATE for MU, STMP and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
03:00PM  Vanda Pharmaceuticals Inc. (VNDA) Bronstein, Gewirtz & Grossman, LLC Class Action Update and Deadline: April 26, 2019 GlobeNewswire
11:00AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of GSM, VALE, VNDA and USX GlobeNewswire
09:52AM  Vanda Pharmaceuticals Inc. (VNDA) Bronstein, Gewirtz & Grossman, LLC Class Action and Deadline: April 26, 2019 ACCESSWIRE
Mar-13-19 10:50PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
05:55PM  VNDA APRIL 26th DEADLINE ALERT: Rosen Law Firm Reminds Vanda Pharmaceuticals Inc. Investors of Important Deadline in First-Filed Case; Encourages Investors With Losses in Excess of $100K to Contact the Firm VNDA GlobeNewswire
03:34PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GSM, VALE, VNDA and NIO GlobeNewswire
12:20PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA ACCESSWIRE
10:07AM  SHAREHOLDER ALERT: ATVI AMRN VNDA USX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
09:51AM  Vanda Pharmaceuticals Inc. (VNDA) Bronstein, Gewirtz & Grossman, LLC Class Action Update and Deadline: April 26, 2019 ACCESSWIRE
Mar-12-19 04:44PM  VNDA ALERT:  Zhang Investor Law Announces the Filing of a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. VNDA GlobeNewswire
Mar-11-19 06:00PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MKL, VNDA and CTL ACCESSWIRE
03:39PM  Vanda (VNDA) Class Action Lawsuit: Bernstein Liebhard LLP Announces a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. VNDA GlobeNewswire
11:19AM  CLASS ACTION UPDATE for AXGN, MKL, VALE and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Mar-08-19 12:00PM  Vanda Pharmaceuticals Inc. (VNDA) Bronstein, Gewirtz & Grossman, LLC Class Action Update and Deadline: April 26, 2019 GlobeNewswire
11:50AM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. - VNDA ACCESSWIRE
09:05AM  CLASS ACTION UPDATE for STMP, VNDA and SYNH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Mar-07-19 09:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. VNDA GlobeNewswire
07:39PM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Vanda Pharmaceuticals Inc. Investors (VNDA) Business Wire
06:39PM  VNDA LAWSUIT ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. - VNDA PR Newswire
05:25PM  LEAD PLAINTIFF DEADLINEALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals, Inc. To Contact The Firm ACCESSWIRE
04:38PM  Vanda (VNDA) Class Action Lawsuit: Bernstein Liebhard LLP Announces A Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. VNDA GlobeNewswire
04:02PM  VNDA CLASS ACTION ALERT: Hagens Berman Alerts Vanda Pharmaceuticals (VNDA) Investors to Securities Class Action and April 26, 2019 Lead Plaintiff Deadline GlobeNewswire
04:01PM  Vanda Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference PR Newswire
11:52AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MAXR, TYME, VNDA and CVS GlobeNewswire
07:57AM  (VNDA) Alert: Johnson Fistel Reminds Investors of Deadline in the Class Action Lawsuit Against Vanda Pharmaceuticals Inc. PR Newswire
Mar-06-19 08:46PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Vanda Pharmaceuticals Inc. Investors GlobeNewswire
02:55PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of STMP, VNDA and CVS ACCESSWIRE
01:40PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA ACCESSWIRE
Mar-05-19 07:31PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Vanda Pharmaceuticals Inc. Investors Business Wire
04:45PM  CLASS ACTION UPDATE for STMP, VNDA and WTW: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
02:52PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
01:50PM  SHAREHOLDER ALERT: DBVT ATVI VNDA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:35AM  Vanda Pharmaceuticals Inc. (VNDA) & Stamps.com Inc. (STMP) - Bronstein, Gewirtz & Grossman, LLC Class Action ACCESSWIRE
08:20AM  Analysis: Positioning to Benefit within IHS Markit, PRA Group, Acacia Communications, Vanda Pharmaceuticals, Gran Tierra Energy, and Kornit Digital Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Mar-04-19 06:40PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Vanda Pharmaceuticals Inc. Investors GlobeNewswire
12:50PM  Vanda Pharmaceuticals Inc. (VNDA) Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Deadline: April 26, 2019 ACCESSWIRE
11:32AM  CLASS ACTION UPDATE for DPLO and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:59AM  IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
10:34AM  Vanda Pharmaceuticals Inc. (VNDA) & Stamps.com Inc. (STMP) - Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
Mar-03-19 06:20PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Diplomat Pharmacy, Vanda Pharmaceuticals, and AVEO Pharmaceuticals and Encourages Investors to Contact the Firm GlobeNewswire
05:35PM  Vanda Pharmaceuticals Inc. (VNDA) & Stamps.com Inc. (STMP) - Bronstein, Gewirtz & Grossman, LLC Class Action Reminder ACCESSWIRE
10:02AM  VNDA INVESTOR ALERT: Rosen Law Firm Reminds Vanda Pharmaceuticals Inc. Investors of Important Deadline in First-Filed Case VNDA Business Wire
08:35AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. VNDA ACCESSWIRE
Mar-02-19 07:00AM  INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. Business Wire
Mar-01-19 05:02PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
04:05PM  VANDA PHARMACEUTICALS INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Vanda Pharmaceuticals Inc. GlobeNewswire
03:49PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. VNDA GlobeNewswire
11:15AM  SHAREHOLDER ALERT: TAP AVP VNDA CVS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
07:20AM  Factors of Influence in 2019, Key Indicators and Opportunity within Vanda Pharmaceuticals, Range Resources, Fortune Brands Home & Security, Dr. Reddy's Laboratories, BWX Technologies, and K12 New Research Emphasizes Economic Growth GlobeNewswire
Feb-28-19 04:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. VNDA ACCESSWIRE
01:53PM  CLASS ACTION ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Significant Losses From Investment In Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) To Contact Brower Piven Before The Lead Plaintiff Deadline GlobeNewswire
12:43PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DNKEY, WRCDF, WCAGY and VNDA GlobeNewswire
11:52AM  RM LAW Announces Class Action Lawsuit Against Vanda Pharmaceuticals Inc. PR Newswire
06:58AM  Is Vanda Pharmaceuticals Inc.s (NASDAQ:VNDA) ROE Of 9.2% Concerning? Simply Wall St.
Feb-27-19 05:43PM  Vanda (VNDA) Class Action Lawsuit: Bernstein Liebhard LLP Announces A Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. - VNDA PR Newswire
03:31PM  INVESTORS ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vanda Pharmaceuticals Inc. (VNDA) ACCESSWIRE
12:50PM  CLASS ACTION UPDATE for ATVI, UXIN, VNDA and CVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:30AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vanda Pharmaceuticals Inc. (VNDA) ACCESSWIRE
09:22AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BRS, AVP, CAG and VNDA GlobeNewswire
07:00AM  New Research Coverage Highlights Cisco, Mattel, Celgene, Vanda Pharmaceuticals, NuStar Energy, and Aon plc Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Feb-26-19 07:46PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA PR Newswire
07:30PM  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Vanda Pharmaceuticals Inc. (VNDA) GlobeNewswire
06:08PM  CLASS ACTION UPDATE for PRGO, W, AMRN and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
06:08PM  Robbins Arroyo LLP: Vanda Pharmaceuticals Inc. (VNDA) Sued for Misleading Shareholders Business Wire
03:47PM  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Vanda Pharmaceuticals, Inc. Business Wire
11:55AM  CLASS ACTION UPDATE for SOGO, DBVT, YRIV and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-25-19 08:16PM  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Vanda Pharmaceuticals Inc. (VNDA) and Encourages VNDA Investors to Contact the Firm GlobeNewswire
04:25PM  EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. VNDA Business Wire
02:05PM  VANDA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals Inc. To Contact The Firm ACCESSWIRE
Feb-21-19 04:43PM  VANDA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals Inc. To Contact The Firm Business Wire
Feb-20-19 03:52PM  Lifshitz & Miller LLP Announces Investigation of Bristow Group Inc., Helius Medical Technologies, Inc., Nordstrom Inc., PriceSmart, Inc., Ryanair Holdings plc, Solid Biosciences Inc., and Vanda Pharmaceuticals Inc. PR Newswire
09:52AM  EQUITY ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Vanda Pharmaceuticals Inc.; Investors are Encouraged to Contact the Firm VNDA GlobeNewswire
07:40AM  New Research: Key Drivers of Growth for Arconic, Vanda Pharmaceuticals, Avaya, Sempra Energy, Forward Industries, and Alamo Group Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Feb-19-19 11:00AM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Vanda Pharmaceuticals Inc. Investors Business Wire
08:05AM  Edited Transcript of VNDA earnings conference call or presentation 13-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-15-19 06:31AM  3 Top Growth Stocks to Buy Right Now Motley Fool
Feb-14-19 03:41PM  Here's Why Vanda Pharmaceuticals Gained as Much as 11.1% Today Motley Fool +9.23%
03:00PM  ONGOING INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. The company's marketed products include HETLIOZ (tasimelteon), a product for the treatment of non-24-hour sleep-wake disorders; and Fanapt (iloperidone), a product for the treatment of schizophrenia. Its products also include Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist that is under the clinical development for the treatment of chronic pruritus in atopic dermatitis and gastroparesis; VTR-297, a small molecule histone deacetylase inhibitor, which is in clinical development stage for the treatment of hematologic malignancies; and VQW-765, a Phase II alpha-7 nicotinic acetylcholine receptor partial agonist. In addition, the company is developing cystic fibrosis transmembrane conductance regulator activators and inhibitors. It markets its products in the United States, Europe, and Israel. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Birznieks GuntherSVP, Business DevelopmentMar 04Sale19.898,788174,767151,251Mar 04 05:02 PM
Reverberi Gian PieroSVP & Chief Commercial OfficerMar 04Sale19.924438,823167,989Mar 04 05:12 PM
Kelly James PatrickEVP & Chief Financial OfficerMar 04Sale19.888,751173,961209,746Mar 04 05:06 PM
Polymeropoulos Mihael HristosPresident and CEOMar 04Sale19.4138,166740,8021,178,970Mar 04 05:10 PM
Polymeropoulos Mihael HristosPresident and CEOMar 01Sale20.226,500131,4241,217,136Mar 04 05:10 PM
Kelly James PatrickEVP & Chief Financial OfficerMar 01Sale20.154,976100,271218,497Mar 04 05:06 PM
Reverberi Gian PieroSVP & Chief Commercial OfficerMar 01Sale20.174388,832168,432Mar 04 05:12 PM
Birznieks GuntherSVP, Business DevelopmentMar 01Sale20.143,74175,325160,039Mar 04 05:02 PM
Birznieks GuntherSVP, Business DevelopmentJan 03Sale26.091,61942,232133,780Jan 04 04:34 PM
Polymeropoulos Mihael HristosPresident and CEOJan 03Sale26.044,447115,8041,163,636Jan 04 04:31 PM
Kelly James PatrickEVP & Chief Financial OfficerJan 03Sale26.091,61942,232193,473Jan 04 04:33 PM
Reverberi Gian PieroSVP & Chief Commercial OfficerJan 02Sale26.591,13030,042138,870Jan 04 04:37 PM
Kelly James PatrickEVP & Chief Financial OfficerJan 02Sale26.474,442117,579195,092Jan 04 04:33 PM
Polymeropoulos Mihael HristosPresident and CEOJan 02Sale26.5010,789285,8581,168,083Jan 04 04:31 PM
Birznieks GuntherSVP, Business DevelopmentJan 02Sale26.474,442117,578135,399Jan 04 04:34 PM
Watkins ThomasDirectorMay 03Option Exercise4.9815,00074,70020,000May 04 04:06 PM